10Dec 2017

ANTIOXIDANT STATUS IN HIV/AIDS ADOLESCENT PATIENTS OF MANIPUR.

  • Department of Biochemistry, Agartala Government Medical College, India.
  • Department of Biochemistry, Jubilee Mission Medical College & Research Institution, India.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Reactive oxygen and nitrogen species are considered as two of the prime suspects for oxidative stress in HIV disease, which in turn stimulate HIV provirus replication and the development of AIDS. Objective: The aim of the present study was to assess early markers of oxidative stress which may diminish the total antioxidant capacity in HIV patients. Pro-oxidant marker Thiobarbituric Acid Reactive species (TBARS) was estimated in serum. Antioxidant parameters including Reduced Glutathione (GSH), Vitamins C and E were also assessed. Design: A cross-sectional study was carried out with 120 HIV-infected adolescents (10-19 years of age) attending out patient department in a tertiary care hospital. Fifty age and sex matched healthy volunteers served as controls. Patients were divided on the basis of their absolute CD4+ counts into 3 groups ? Group 1 (<200 CD4+ cells/mm3), Group 2 (200-499 CD4+ cells/mm3), Group 3 (>500 CD4+ cells/mm3). Results: Mean serum TBARS level were significantly higher in GR-1 (8.54 ? 1.19 nmol/mL), GR-2 (7.69 ? 0.84 nmol/mL) and GR-3 (6.97 ? 0.9 nmol/mL) than in healthy subjects (4.33 ? 0.93 nmol/mL). Also, there was significant (p < 0.05) decrease in the levels of vitamin E, vitamin C and GSH among GR-1 and GR-2, though the decrease in levels of vitamin E and vitamin C in GR-3 patients when compared to controls was found to be insignificant (p > 0.05). The TBARS exhibited a negative correlation when compared with CD4+counts whereas antioxidant markers showed a positive correlation. Conclusion: HIV-infected adolescents have an inadequate antioxidant status, which could influence the progression to AIDS. An adequate micronutrient status and reduced glutathione (GSH) could improve the clinical condition in these patients and minimize free radical production and cellular oxidative stress. More detailed studies need to be conducted at this age group patient to correlate the redox imbalance and disease progression with antioxidant supplementation.


  1. Rasool ST, Tang H, Wu J, Li W,MukhtarMM, Zhang J, Mu Y, Xing HX, Wu J and Zhu Y. Immunol Letters 2008;117:161-67.
  2. Global summary of AIDS epidemic. (2007).
  3. Evans P, Halliwell B. Micronutrients: oxidant/antioxidant status. Br J Nutr 2001;85(suppl 2):S67?74.
  4. Stephensen CB. Vitamin A, infection and immune function.Annu Rev Nutr 2001;21:167?92.
  5. Tang AM, Graham NM, Kirby AJ, McCall LD, Willett WC, Saah AJ. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1(HIV-1)-infected homosexual men. Am J Epidemiol 1993;138:937?51.
  6. Tang AM, Graham NM, Semba RD, Saah AJ. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS 1997;11:613?20.
  7. Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC, Herzenberg LA.Glutathione deficiency is associated with impaired survival in HIV disease. Proceedings of the National Academy of Sciences of the United States of America 94 1997; 1967e1972.
  8. National AIDS Control Organization (NACO), Ministry of Health and Family Welfare. HIV/AIDS Specialist training and reference module 2003, Government of India, New Delhi 5-8.
  9. Center for Disease Control (CDC). Morb.Mortal.Wiley Rep 1993;14, 1.
  10. Montoya CJ, Jaimes F, Higuita EA, Paez SC, Estrada S, Gutierrez F, Amariles P, Giraldo N, Penaloza C, Rugeles MT. Antiretroviral effect of lovastatin on HIV-1 Infected individual without highly active antiretroviral therapy (the live study): a phase II randomized clinical trial. Trials 2009; 10:41.l
  11. Yagi K.: ChemPhys Lipids 1978; 45: 337-51.
  12. Natelson S. Vitamin E (Tocopherols). In: Charles C Thomas, editor. Technics of clinical chemistry.3rd edition. USA. Illionis. 1971, 756-58
  13. Omage ST: Ascorbic acid analysis II. Determination after derivatization with 2, 4, ? Dinitrophenylhydrazine.Methods inEnzymology1979;62:7-8.
  14. Quantichrom TM Glutathione Assay kit (DIGIT-250). Colorimetric determination of reduced glutathione at 412 nm.www.bioassaysys.com 2009 by BioAssay Systems. 3191Corporate place, Hayward, CA 94545, USA
  15. Kruzich LA, Marquis GS, Wilson CM, Stephensen CB. HIV-infected US youth are at high risk of obesity and poor diet quality: a challenge for improving short- and long-term health outcomes. J Am Diet Assoc 2004;104:1554?60.
  16. Stephensen CB, Marquis GS, Douglas SD, Wilson CM. Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents. J AcquirImmunDeficSyndr 2005;38:180 ?90.
  17. ZwartLL, MeermanJHN, CommandeurJNM and VermeulenNPE. Free RadicBiol Med 1999; 26 (1/2): 202.
  18. Plit ML, Theron AJ, Fickl H, VanRensburg CE, Pendel S and Anderson R. Int J Tuberc Lung Dis 1998; 2: 590-96.
  19. Rwangabwoba JM, Fischman H and Semba RD; Int J Tuberc Lung Dis 1998; 2: 771-73.
  20. Dubey SS, Sinha KK and Gupta JP. Indian J PhyPharmacol 1985; 29 : 111-14.
  21. Stambullian M, Feliu S, Slobodianik HN.Nutritional status in patients with HIV infection and AIDS. British Journal of Nutrition 2007; 98(1):140-3
  22. Buhl R, Holroyd KJ, Mastrangeli A, Cantin AM, Jaffe HA, Wells FB, Saltini C and Crystal RG. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 2 1989; 1294-97.
  23. de Quay B, Malinverni R and Lauterburg BH. Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 6 1992; 815-19.
  24. Roederer M, Staal FJT, Ela SW, Herzenberg LA andHerzenberg LA. N-Acetylcysteine: potential for AIDS therapy. Pharmacology 46 1993; 121-29.

[Subhojit Das and Asitava Roy. (2017); ANTIOXIDANT STATUS IN HIV/AIDS ADOLESCENT PATIENTS OF MANIPUR. Int. J. of Adv. Res. 5 (Dec). 10-14] (ISSN 2320-5407). www.journalijar.com


DR SUBHOJIT DAS
Assistant Professor, Department of Biochemistry, Agartala Government Medical College, Agartala-799006, Tripura West, India

DOI:


Article DOI: 10.21474/IJAR01/5931      
DOI URL: http://dx.doi.org/10.21474/IJAR01/5931